The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from phase 2b study of selinexor in combination with carfilzomib, daratumumab, or pomalidomide in patients with multiple myeloma (MM) relapsing on current therapy.
 
Noa Biran
Employment - Boehringer Ingelheim (I)
Honoraria - Abbvie; Bristol-Myers Squibb; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Sanofi
Research Funding - Amgen; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Merck
 
David Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
 
Harsh Parmar
Consulting or Advisory Role - Cellectar; Cellectar
 
Pooja Phull
Consulting or Advisory Role - Pfizer
 
Kimberley Doucette
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Cellectar
Research Funding - Janssen
 
Jaeil Ahn
Consulting or Advisory Role - KeifeRx
 
Rena Feinman
Stock and Other Ownership Interests - COTA (I)
Honoraria - Bristol-Myers Squibb (I); Envision Pharma Group (I); Menarini Silicon Biosystems (I); Merck (I); Pfizer (I); Sebia (I)
Consulting or Advisory Role - Bristol-Myers Squibb (I); Envision Pharma Group (I); Menarini Silicon Biosystems (I); Merck (I); Pfizer (I); Sebia (I)
 
Joshua Zenreich
No Relationships to Disclose
 
Palka Anand
No Relationships to Disclose
 
Kristin Ivanovski
No Relationships to Disclose
 
Monique Pace
No Relationships to Disclose
 
Alexandra Della Pia
No Relationships to Disclose
 
Bianca DeAgresta
Employment - Bristol-Myers Squibb (I)
 
Adolfo Aleman
No Relationships to Disclose
 
Ella Rutanen
No Relationships to Disclose
 
Marie Layton
No Relationships to Disclose
 
Genevieve Breeze
No Relationships to Disclose
 
Aimee Chappell
No Relationships to Disclose
 
Susan Kumka
Consulting or Advisory Role - ACCC/Pfizer; Johnson & Johnson
Speakers' Bureau - Karyopharm Therapeutics
 
David Siegel
Stock and Other Ownership Interests - COTA
Honoraria - BMS; Envision Pharma Group; Menarini Silicon Biosystems; Merck; Pfizer; Sebia
Consulting or Advisory Role - BMS; Envision Pharma Group; Menarini Silicon Biosystems; Merck; Pfizer; Sebia